Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing popularity of hrt fueling demand for compounded medications, increasing prevalence of hormonal imbalance problems, and government regulations and initiatives.
The compounding pharmacy market is segmented as below:
By Product
- Topical medications
- Oral medications
- Parenteral medications
- Others
By Therapeutic Area
- Pain management
- Hormone replacement
- Dermal disorders
- Others
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the compounding pharmacy market covers the following areas:
- Compounding pharmacy market sizing
- Compounding pharmacy market forecast
- Compounding pharmacy market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
Executive Summary
The following companies are recognized as the key players in the global compounding pharmacy market: ACPHARM QUEENSLAND Pty Ltd., Advance Pharmacy, Athenex Inc., B.Braun SE, Doughertys Pharmacy, Fagron NV, Fresenius SE and Co. KGaA, Institutional Pharmacy Solutions, ITC Compounding Pharmacy, Lee Silsby Compounding Pharmacy, McGuff Co. Inc., Nephron Pharmaceuticals Corp., Olympia Pharmacy, PenCol Specialty Pharmacy, QuVa Pharma Inc., Rx3 Compounding Pharmacy, Triangle Compounding Pharmacy, Valor Compounding Pharmacy, Village Compounding Pharmacy, and Wedgewood Village Pharmacy LLC.Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is rising popularity of personalized medicines."
According to the report, one of the major drivers for this market is the growing popularity of hrt fueling demand for compounded medications.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- ACPHARM QUEENSLAND Pty Ltd.
- Advance Pharmacy
- Athenex Inc.
- B.Braun SE
- Doughertys Pharmacy
- Fagron NV
- Fresenius SE and Co. KGaA
- Institutional Pharmacy Solutions
- ITC Compounding Pharmacy
- Lee Silsby Compounding Pharmacy
- McGuff Co. Inc.
- Nephron Pharmaceuticals Corp.
- Olympia Pharmacy
- PenCol Specialty Pharmacy
- QuVa Pharma Inc.
- Rx3 Compounding Pharmacy
- Triangle Compounding Pharmacy
- Valor Compounding Pharmacy
- Village Compounding Pharmacy
- Wedgewood Village Pharmacy LLC